Han Peng, Li Fan, Cao Peng, Hu Shan, Kong Kangle, Deng Yu, Zu Yukun, Zhao Bo
Department of Thoracic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China.
Medicine (Baltimore). 2020 May 29;99(22):e20166. doi: 10.1097/MD.0000000000020166.
Currently, COVID-19 has made a significant impact on many countries in the world. However, there have been no reported cases of pulmonary lobectomy with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2) infection. We are the first to report such a case.
We report a 63-year-old Wuhan male patient with smoking history of 40 cigarettes per day for 40 years. He sought medical consultation for right lower lung nodules found by CT scan.
The patient's postoperative pathological diagnosis was squamous cell carcinoma of the right lower lung. On the fourth day after the operation, the real-time reverse transcription polymerase chain reaction test showed a positive result. After the operation, we routinely give symptomatic treatments such as anti-infection, nebulization and oxygen inhalation. We also change antibiotics several times depending on the patient's condition.
The patient's condition continued to deteriorate. On the fifth day after surgery, the patient died despite medical treatment.
We are the first to report the diagnosis and treatment process of patients with COVID-19 during perioperative period of lobectomy. It provides a case for the postoperative management of such patients.
目前,新型冠状病毒肺炎(COVID-19)已对世界上许多国家产生了重大影响。然而,尚无关于严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染患者行肺叶切除术的报道。我们是首例报告此类病例的。
我们报告一名63岁的武汉男性患者,有40年吸烟史,每天吸烟40支。他因CT扫描发现右下肺结节而寻求医疗咨询。
患者术后病理诊断为右下肺鳞状细胞癌。术后第4天,实时逆转录聚合酶链反应检测结果呈阳性。术后,我们常规给予抗感染、雾化和吸氧等对症治疗。我们还根据患者情况多次更换抗生素。
患者病情持续恶化。术后第5天,患者虽经治疗仍死亡。
我们是首例报告肺叶切除围手术期COVID-19患者的诊断和治疗过程的。它为这类患者的术后管理提供了一个病例。